See the DrugPatentWatch profile for Comirnaty
When does the Comirnaty (Pfizer-BioNTech COVID-19 vaccine) patent expire in 2041?
Public information on “the” Comirnaty patent expiration date is often complicated because there is not one single patent that governs all aspects of the product. Pfizer’s Comirnaty is protected by multiple patents and patent families that can expire in different years, depending on jurisdiction and the specific claim. As a result, “2041” typically reflects the expiration of at least one relevant patent in a particular family/jurisdiction, not necessarily the last protection covering every component of Comirnaty worldwide.
Why are there different expiration years for Comirnaty patents?
Patent expiry timing can vary because:
- Different patents cover different inventions (for example, formulation, manufacturing methods, specific genetic construct details, or related improvements).
- Patents are filed and processed at different times across countries, which changes their legal expiry dates.
- Some patents can have different kinds of term adjustments or extensions depending on local law (and whether any exclusivity-like mechanisms apply).
So users often see a “2041” date tied to a specific patent set, while other patents for Comirnaty may end earlier or later.
Does 2041 mean Comirnaty is guaranteed to face no competition until then?
Not necessarily. Even if some patents last until around 2041, competition (for example, by other vaccines or potential biosimilar-like products, depending on the product category and regulatory pathway) may still occur using non-infringing designs, different protected claims, or products that are not covered by that specific patent family. Also, regulatory approval and patent protection are separate tracks: a product can be approved even while patent disputes or injunction risks exist.
How can you verify the “2041” date for your country?
To confirm whether 2041 is the relevant expiry for you, you typically need to match:
- the exact patent number(s) or family identified as expiring in 2041,
- the country/region you care about (US, EP/EU, UK, etc.),
- and whether that expiry is for the primary patent term, plus any adjustments.
If you share the country (or the specific patent/publication number you saw), I can help interpret what that 2041 date corresponds to and what it would practically affect.
What to do next if you’re looking for a specific patent schedule
If your goal is a precise timeline (for example, “Can generics/biosimilars enter before 2041?”), you’ll want:
- the patent identifiers tied to “2041,” and
- the claims covered by those patents (what part of Comirnaty they protect).
Without those details, “2041” is best treated as a reference point for a particular protection layer rather than a universal end date for all Comirnaty IP.
---
Sources
No sources were provided in the prompt. If you paste the patent number, patent family link, or the jurisdiction where you saw “2041,” I can look up and explain the specific expiry timing and implications.